Propeller Health, a digital therapeutics company has announced the launch of My Pharmacy feature, connecting Propeller u...
Generex Biotechnology Corporation has announced that the company has entered into a letter of intent (LOI) to acquire Pa...
On the final day of the largest biotechnology and pharmaceutical partnering week at the Juvenescence Longevity Showcase ...
Global combination device testing laboratory, Medical Engineering Technologies (MET), has newly appointed Kevin Claris a...
Embrace by Empatica has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for us...
Volkan Gunduz, PhD, Senior Oncology and Hematology Analyst at GlobalData, a leading data and analytics company, offers h...
Vast Therapeutics, a preclinical stage pharmaceutical company delivering nitric oxide in a powder-based form has announc...
Neosensory, a company that pioneers devices to send information to the brain non-invasively has announced that it has re...
A more comfortable and reliable blood-sugar monitoring system is being designed at KTH Royal Institute of Technology in ...
Aphria Inc. announced that it had completed its previously announced acquisition of CC Pharma GmbH ("CC Pharma...
Medical device company, REVA Medical has announced the geographic expansion of its commercial operations in seven Europe...
Sandoz Inc., a Novartis division, and Pear Therapeutics has announced the US commercial launch of reSET-O(TM) for patien...
Forbius, a clinical-stage company developing biologics for the treatment of cancer and fibrosis, announced that the firs...
Medidata has announced the addition of executive vice president of Digital and AI Solutions, Sastry Chilukuri to its sen...
Leica Biosystems, the global leader in pathology workflow solutions announced today that the US Patent Office has grante...
Generex Biotechnology Corporation has announced that the company has completed the acquisition of 51% of Regentys Corpor...
MYnd Analytics, a predictive analytics company aimed at improving the delivery of mental health services through the com...
Lupin has announced that the European Commission (EC) has approved NaMuscla® (mexiletine) for the symptomatic treatm...
